Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis.
Peter C TaylorBryan DownieLing HanRachael HawtinAngie HertzRobert John MootsTsutomu TakeuchiPublished in: Rheumatology and therapy (2024)
Clinicaltrials.gov: NCT02889796; NCT02873936; NCT02886728.